Urinary Urge Incontinence (UUI)
0
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
AxonicsCA - Irvine
2 programsAxonics SNM SystemN/A1 trial
Axonics SNM System INS Model 5101N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
AxonicsAxonics SNM System INS Model 5101
AxonicsAxonics SNM System
Clinical Trials (2)
Total enrollment: 199 patients across 2 trials
PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB
Start: Sep 2025Est. completion: Dec 202755 patients
N/ARecruiting
F15 Recharge Free Axonics SNM System Clinical Study
Start: Dec 2023Est. completion: Dec 2027144 patients
N/AActive Not Recruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 199 patients
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.